Xiaochen Liu
Impact in
- Nephrology top 10%
-
- Immunotherapy and Immune Responses
Papers in
-
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 3
- Wnt/β-catenin signaling in development and cancer 2
- Biochemical and Molecular Research 2
- RNA modifications and cancer 2
- Oncology 5
- CAR-T cell therapy research 2
- Co-authors
- Dangge Wang (4 shared papers)Zitong Zhao (4 shared papers)Yaping Li (4 shared papers)Xiangshi Sun (4 shared papers)Ping Xiao (3 shared papers)Zhirong Lin (2 shared papers)Hui He (2 shared papers)Jue Wang (3 shared papers)
- Journals
- Oncogene (2 papers)Clinical Epigenetics (1 paper)Biochemical and Biophysical Research Communications (1 paper)Nano Letters (1 paper)Advanced Functional Materials (1 paper)
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Xiaochen Liu
25 papers receiving 680 citations
Peers
Comparison fields: 5 of 86
- Nephrology 57
- Immunology 151
- Cancer Research 87
- Biomaterials 57
- Molecular Biology 285
Countries citing papers authored by Xiaochen Liu
This map shows the geographic impact of Xiaochen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Liu more than expected).
Fields of papers citing papers by Xiaochen Liu
This network shows the impact of papers produced by Xiaochen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Liu. The network helps show where Xiaochen Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 73 | |
| 2 | 2021 | 71 | |
| 3 | 2019 | 67 | |
| 4 | 2011 | 55 | |
| 5 | 2013 | 54 | |
| 6 | 2019 | 40 | |
| 7 | 2021 | 35 | |
| 8 | 2017 | 34 | |
| 9 | 2021 | 33 | |
| 10 | 2016 | 31 | |
| 11 | 2021 | 29 | |
| 12 | 2020 | 27 | |
| 13 | 2022 | 26 | |
| 14 | 2021 | 19 | |
| 15 | 2018 | 18 | |
| 16 | 2018 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2022 | 12 | |
| 19 | 2021 | 9 | |
| 20 | 2023 | 7 |
About Xiaochen Liu
Xiaochen Liu is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pharmacology, having authored 25 papers that have together received 686 indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Biochemical and Molecular Research (2 papers), Immunotherapy and Immune Responses (2 papers), RNA modifications and cancer (2 papers), CAR-T cell therapy research (2 papers) and Berberine and alkaloids research (2 papers). The work is most often cited by research in Nephrology (57 citations), Immunology (151 citations), Cancer Research (87 citations), Biomaterials (57 citations) and Molecular Biology (285 citations). Xiaochen Liu has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Dangge Wang, Zitong Zhao, Yaping Li, Xiangshi Sun, Ping Xiao, Zhirong Lin, Hui He, Jue Wang, Hossein Elgafy and Lei Fang. Their work appears in journals such as Oncogene, Clinical Epigenetics, Biochemical and Biophysical Research Communications, Nano Letters and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.